Jane Street’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-52,420
Closed -$896K 5970
2025
Q1
$896K Sell
52,420
-453,171
-90% -$7.74M ﹤0.01% 3193
2024
Q4
$12.5M Buy
505,591
+181,426
+56% +$4.49M ﹤0.01% 638
2024
Q3
$9.24M Buy
324,165
+183,848
+131% +$5.24M ﹤0.01% 799
2024
Q2
$3.7M Buy
140,317
+72,712
+108% +$1.92M ﹤0.01% 2007
2024
Q1
$2.18M Sell
67,605
-546,736
-89% -$17.7M ﹤0.01% 2211
2023
Q4
$25.9M Buy
614,341
+285,829
+87% +$12M 0.01% 436
2023
Q3
$12.6M Buy
328,512
+167,466
+104% +$6.43M ﹤0.01% 687
2023
Q2
$3.06M Buy
161,046
+63,624
+65% +$1.21M ﹤0.01% 1951
2023
Q1
$1.51M Sell
97,422
-221,649
-69% -$3.44M ﹤0.01% 2358
2022
Q4
$5.66M Buy
319,071
+302,965
+1,881% +$5.38M ﹤0.01% 1066
2022
Q3
$90K Buy
+16,106
New +$90K ﹤0.01% 4934
2022
Q2
Sell
-41,178
Closed -$226K 5874
2022
Q1
$226K Buy
41,178
+9,424
+30% +$51.7K ﹤0.01% 4608
2021
Q4
$270K Sell
31,754
-47,002
-60% -$400K ﹤0.01% 4129
2021
Q3
$684K Sell
78,756
-38,962
-33% -$338K ﹤0.01% 3093
2021
Q2
$1.24M Buy
117,718
+104,172
+769% +$1.1M ﹤0.01% 2316
2021
Q1
$217K Buy
+13,546
New +$217K ﹤0.01% 4214
2020
Q4
Sell
-14,713
Closed -$518K 4125
2020
Q3
$518K Sell
14,713
-11,608
-44% -$409K ﹤0.01% 2407
2020
Q2
$640K Buy
26,321
+14,331
+120% +$348K ﹤0.01% 2319
2020
Q1
$186K Buy
+11,990
New +$186K ﹤0.01% 2917